Abstract
The recombinant adeno-associated virus (rAAV) have several advantages which contribute to their increasing use in gene therapy. Broad tropism, ability to transduce cells post-mitotic or terminally differentiated, low frequency integration, immune response moderate and high titer sustained expression is rAAV characteristics that contribute to the prospect of its application safe and succes…